News and Announcements
D Coin has been registered to provide Digital Currency Exchange services by AUSTRAC
- Published April 11, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Perth based crypto start up D Coin has been registered to provide Digital Currency Exchange services by AUSTRAC, pursuant to subsection 76E(2) of the Anti-Money Laundering and Counter-Terrorism Financing Amendment Act 2017 (AML/CTF Act Amendment Act 2017)
www.austrac.gov.au/digital-currency-exchange-providers
Commenting on the state of regulation in Australia D Coin Co-Founder & General Manager Michael Whitehorn said “Our industry is working closely with regulators to ensure we are advocating and providing input to help define legislation, thus making it appropriate and fit for purpose when it arrives. Through our membership of the Australian Digital Commerce Association (www.adca.asn.au) this type of engagement also extends to banking and other commercial and compliance related relationships. The overall goal here being to fully legitimise the cryptocurrency industry enabling further adoption and importantly protection to all participants”
About D Coin
D Coin is a unique vertically integrated digital currency business, owned and operated in Australia offering a digital asset investment fund open to retail, wholesale and commercial investors.
The fund operates in the digital asset realm combining multiple proprietary activities across technology, financial markets and cryptocurrency, fully immersing our investors into the fastest asset growth class available.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
